Fachrepositorium Lebenswissenschaften

16 Treffer

Seiten

Suche

Publisso-Menue

Seiten

Long-term prospective outcome data using EndoPredict as risk stratification and chemotherapy decision biomarker in hormone receptor-positive, HER2-negative early breast cancer

2024 . Klein, Evelyn | Kiechle, Marion | Josipovic, Adriana | Anders, Sophie-Isabelle | Noske, Aurelia | Mogler, Carolin | Hapfelmeier, Alexander | Ettl, Johannes

EDI3 knockdown in ER-HER2+ breast cancer cells reduces tumor burden and improves survival in two mouse models of experimental metastasis

2024 . Glotzbach, Annika | Rohlf, Katharina | Gonscharow, Anastasia | Lüke, Simon | Demirci, Özlem | Begher-Tibbe, Brigitte | Overbeck, Nina | Reinders, Jörg | Cadenas, Cristina | Hengstler, Jan G. | Edlund, Karolina | Marchan, Rosemarie

Miniaturized protein profiling permits targeted signaling pathway analysis in individual circulating tumor cells to improve personalized treatment

2024 . Rivandi, Mahdi | Franken, André | Yang, Liwen | Abramova, Anna | Stamm, Nadia | Eberhardt, Jens | Gierke, Berthold | Beer, Meike | Fehm, Tanja | Niederacher, Dieter | Pawlak, Michael | Neubauer, Hans

On-treatment biopsies to predict response to neoadjuvant chemotherapy for breast cancer

The REMAR (Rhein-Main-Registry) real-world study: prospective evaluation of the 21-gene breast recurrence score® assay in addition to Ki-67 for adjuvant treatment decisions in early-stage breast cancer

Combined inhibition of EZH2 and ATM is synthetic lethal in BRCA1-deficient breast cancer

Knockdown of the prognostic cancer stem cell marker Musashi-1 decreases radio-resistance while enhancing apoptosis in hormone receptor-positive breast cancer cells via p21WAF1/CIP1

2021 . Troschel, Fabian M | Palenta, Heike | Borrmann, Katrin | Heshe, Kristin | Hua, San Hue | Yip, George | Kiesel, Ludwig | Eich, Hans Theodor | Götte, Martin | Greve, Burkhard

Platelet-expressed immune checkpoint regulator GITRL in breast cancer

2021 . Zhou, Yanjun | Heitmann, Jonas S. | Clar, Kim | Kropp, Korbinian | Hinterleitner, Clemens | Engler, Tobias | Koch, André | Hartkopf, Andreas D. | Zender, Lars | Salih, Helmut | Maurer, Stefanie | Hinterleitner, Clemens

Cytoplasmic LXR expression is an independent marker of poor prognosis for patients with early stage primary breast cancer

2021 . Shao, Wanting | Kuhn, Christina | Mayr, Doris | Ditsch, Nina | Kailuwait, Magdalena | Wolf, Verena | Harbeck, Nadia | Mahner, Sven | Jeschke, Udo | Cavaillès, Vincent | Sixou, Sophie

Magnetic resonance imaging and ultrasound for prediction of residual tumor size in early breast cancer within the ADAPT subtrials

Seiten